US Patent Issued to PROTARA THERAPEUTICS on Feb. 17 for "Combination of non-viable cells of Streptococcus pyogenes and immune checkpoint inhibitor for the treatment of triple negative breast cancer and non-muscle invasive bladder cancer" (New York Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,514, issued on Feb. 17, was assigned to PROTARA THERAPEUTICS INC. (New York).

"Combination of non-viable cells of Streptococcus pyogenes and immune checkpoint inhibitor for the treatment of triple negative breast cancer and non-muscle invasive bladder cancer" was invented by Flavia Gerelli Ghiraldini (New York), Jacqueline Zummo (New York) and Maurizio Mauro (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating triple negative breast cancer or non-muscle invasive bladder cancer in a subject comprising administering to the subject a composition comprising non-viable cells of Streptococcus pyoge...